The usual cause for the fund is to invest in rounds with 7 partakers. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, The Column Group, Redmile Group. In the next rounds fund is usually obtained by Redmile Group, Versant Ventures, Trinitas Capital.
The increased amount of exits for fund were in 2018. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of more than 100 millions dollars. The top activity for fund was in 2015.
Among the most popular portfolio startups of the fund, we may highlight Gritstone Oncology. Among the most successful fund investment fields, there are Biotechnology, Therapeutics.
| Fund Name | Location |
| Anhui Provincial Emerging Industry Investment | Anhui, China, Hefei |
| Cedarlake Capital | China, Shanghai |
| Corriente Biotechnology Partners | - |
| Documentum | California, Pleasanton, United States |
| Flightpath Ventures | California, San Francisco, United States |
| Fond fondov | District of Zvolen, Region of Banská Bystrica, Slovakia |
| Holdun Investments Management | Canada, Montreal, Quebec |
| InterGen Capital | Alberta, Calgary, Canada |
| Key Venture Partners | Boston, Massachusetts, United States |
| MEDTEQ | Canada, Montreal, Quebec |
| New Investment Solutions | Liechtenstein, Oberland, Vaduz |
| Other Corporate Investors | - |
| Praktikerinvest | Stockholm, Stockholm County, Sweden |
| Reuters Venture Capital | England, London, United Kingdom |
| Schroder Ventures | England, London, United Kingdom |
| Shanghai Jianxin Kangying Venture Capital Management | China, Shanghai |
| Triangle Capital Corporation | North Carolina, Raleigh, United States |
| WTP Capital | Falls Church, United States, Virginia |
| YA Global Master SPV | Mountainside, New Jersey, United States |
| Zhongxing Hongtai Touzi | China, Shaanxi, Xian Shi |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Gritstone Oncology | $102M | 20 Oct 2015 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Gritstone Oncology | $102M | 20 Oct 2015 | California, United States |
